Tigh­ter requi­re­ments for manu­fac­tu­r­ers and increased lia­bi­li­ty risks

Medi­cal Device Regu­la­ti­on – clas­si­fi­ca­ti­on, qua­li­ty manage­ment, UDI label­ling and liability

An artic­le by Miri­am Schuh in the spe­cia­list jour­nal Haft­pflicht inter­na­tio­nal – Recht und Ver­si­che­rung (PHi), (“Inter­na­tio­nal public lia­bi­li­ty – law and insu­rance”) issue 2017, no. 5

Sin­ce May of this year, the new Euro­pean regu­la­ti­ons for medi­cal devices and in vitro dia­gno­stic medi­cal devices have been in force. The aim of the new regu­la­ti­ons is to crea­te a hig­her degree of safe­ty for pati­ents and users. Accor­din­gly, the obli­ga­ti­ons of manu­fac­tu­r­ers in par­ti­cu­lar have been exten­ded and tightened. 

Miri­am Schuh explains what real­ly mat­ters when it comes to clas­si­fi­ca­ti­on, qua­li­ty manage­ment, UDI and lia­bi­li­ty for manu­fac­tu­r­ers, and why the­re may be bot­t­len­ecks, par­ti­cu­lar­ly for small and medium-sized businesses. 

More infor­ma­ti­on on PHi, issue 2017, no. 5


Stay up-to-date

We use your email address exclusively for sending our newsletter. You have the right to revoke your consent at any time with effect for the future. For further information, please refer to our privacy policy.